Category Archives: Compulsory Licensing

Document exclusivity weakens Norwegian pandemic preparedness

Posted on June 21, 2018 by donttradeourlivesaway

Source: Dagens Medisin | June 20, 2018 IMAGINE THAT A large global o, break of contagious disease also includes Norway, such as a new flu-like disease with high risk of transmission and mortality. Imagine that there is only one effective drug, … Continue reading →

Posted in Compulsory Licensing, Patent, Patents | Leave a comment

For the first time the court has allowed the Russian pharmaceutical companies to produce a similar drug from USA

Posted on June 5, 2018 by donttradeourlivesaway

Source: HandofMoscow | June 3, 2018 by Andry Kut The arbitration court of Moscow satisfied the request of the Russian pharmaceutical company “Ukrenergo” on the issuance of a license to use a patent of the American Corporation Celgene in connection with a … Continue reading →

Posted in Compulsory Licensing, Uncategorized | Leave a comment

New laws needed now to save lives: FTPL statement on new IP policy

Posted on June 1, 2018 by donttradeourlivesaway

  Source: Fix the Patent Laws Intellectual property policy welcomed after nine years of development JOHANNESBURG, 31 MAY 2018 – Yesterday, after nine years of development, the Department of Trade and Industry (the dti) finally published the Intellectual Property Policy of the … Continue reading →

Posted in Compulsory Licensing, Doha Declaration, Fix the patent law, Patent Opposition, Patent Term Extension, TRIPS, Uncategorized | Leave a comment

Norwegian parliament turns down proposal to issue Spinraza compulsory license

Posted on May 30, 2018 by donttradeourlivesaway

On Thursday last week a majority vote in the Norwegian parliament Stortinget turned down a proposal to request that the Government issue a compulsory license for the drug Spinraza (nusinersen), which is used to treat the serious congenital condition Spinal … Continue reading →

Posted in Access to Medicins, Compulsory Licensing | Leave a comment

WHA agrees on drafting of roadmap for access to medicines and vaccines; US blasts compulsory licences

Posted on May 25, 2018 by donttradeourlivesaway

Source: Intellectual Property Watch|25th May 2018 The World Health Assembly yesterday agreed on a roadmap to be designed by the World Health Organization in consultation with member states to facilitate access to medicines and vaccines, including actions and activities for … Continue reading →

Posted in Access to Medecines, Compulsory Licensing, Vaccines | Leave a comment

Scottish government urged to make breast cancer drug available to Scots

Posted on April 25, 2018 by donttradeourlivesaway

Source: The National | April 24, 2018 A WOMAN forced to choose between accessing a breast cancer drug and moving back to be near family in Scotland has urged Holyrood (Scottish government) to help patients. Dunise MacIver was working in London when doctors … Continue reading →

Posted in Access to Medicins, Cancer, Compulsory Licensing, Diseases/Therapies, Drug prices | Leave a comment

The Power of TRIPS Flexibilities in Medicines Procurement

Posted on April 11, 2018 by donttradeourlivesaway

Source: Medicine Law & Policy The government of Malaysia has began to roll out treatment of people infected with the hepatitis C virus (HCV).  Treatment will be a combination of antivirals (sofosbuvir and daclatasvir) from generic producers, including the Egyptian company … Continue reading →

Posted in Compulsory Licensing, TRIPS flexibilities, Uncategorized | Leave a comment

Time to explore the licence to make new TB drugs more accessible

Posted on March 21, 2018 by donttradeourlivesaway

By Leena Menghaney, The Hindu BusinessLine | March 16, 2018 The World Health Organization (WHO) estimates that tuberculosis (TB) prevalence is decreasing at a rate of about 2 per cent per year worldwide and that timely diagnosis and treatment have … Continue reading →

Posted in Compulsory Licensing, TRIPS flexibilities, Tuberculosis (TB), Uncategorized | Leave a comment

Indian civil society pushes for ‘Government Use’ compulsory license on MDR-TB Drugs

Posted on March 13, 2018 by donttradeourlivesaway

Source: Lawyers Collective | 12 March 2018 Survivors of drug resistant tuberculosis, health organisations and the TB community in India and across the globe have appealed to the Prime Minister of India to issue a government use compulsory license for … Continue reading →

Posted in Compulsory Licensing, TRIPS flexibilities, Tuberculosis (TB), Uncategorized | Leave a comment

Health bodies push for compulsory licence for two drugs on MDR-TB

Posted on March 13, 2018 by donttradeourlivesaway

Source: PTI Published: India Today | March 13, 2018 New Delhi: Survivors of drug-resistant tuberculosis, health organisations and the TB community have appealed to Prime Minister Narendra Modi to allow issuance of compulsory licence for two of the essential drugs … Continue reading →

Posted in Compulsory Licensing, Patent, Tuberculosis (TB), Uncategorized | Leave a comment